Tryp Therapeutics Analysis

TRYPFDelisted Stock  USD 0.05  0  6.89%   
Tryp Therapeutics is overvalued with Real Value of 0.0465 and Hype Value of 0.05. The main objective of Tryp Therapeutics otc analysis is to determine its intrinsic value, which is an estimate of what Tryp Therapeutics is worth, separate from its market price. There are two main types of Tryp Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Tryp Therapeutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Tryp Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Tryp OTC Stock Analysis Notes

About 47.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.13. Tryp Therapeutics had not issued any dividends in recent years. Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company was incorporated in 2019 and is based in Kelowna, Canada. Tryp Thrapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Tryp Therapeutics is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Tryp Therapeutics contact Dr MSIB at 833 811 8797 or learn more at https://www.tryptherapeutics.com.

Tryp Therapeutics Investment Alerts

Tryp Therapeutics is not yet fully synchronised with the market data
Tryp Therapeutics has some characteristics of a very speculative penny stock
Tryp Therapeutics has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (7.49 M) with profit before overhead, payroll, taxes, and interest of 0.
Tryp Therapeutics has accumulated about 2.85 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Roughly 47.0% of the company outstanding shares are owned by corporate insiders

Tryp Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tryp Therapeutics's market, we take the total number of its shares issued and multiply it by Tryp Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Tryp Therapeutics Predictive Daily Indicators

Tryp Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tryp Therapeutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Tryp OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Tryp Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tryp shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Tryp Therapeutics. By using and applying Tryp OTC Stock analysis, traders can create a robust methodology for identifying Tryp entry and exit points for their positions.
Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company was incorporated in 2019 and is based in Kelowna, Canada. Tryp Thrapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Tryp Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Tryp OTC Stock

If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins